CVS HEALTH CORPORATION Current Foreign Tax Expense (Benefit)
CVS HEALTH CORPORATION (CVS) reported Current Foreign Tax Expense (Benefit) of $114.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentForeignTaxExpenseBenefit · last filed 2026-02-10
- CVS HEALTH CORPORATION current foreign tax expense (benefit) for fiscal 2025 was $114.00M, a 216.67% increase from fiscal 2024.
- CVS HEALTH CORPORATION current foreign tax expense (benefit) for fiscal 2024 was $36.00M, a 620.00% increase from fiscal 2023.
- CVS HEALTH CORPORATION current foreign tax expense (benefit) for fiscal 2023 was $5.00M.
| Period end | Current Foreign Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $114.00M 10-K · filed 2026-02-10 |
| 2024-12-31 | $36.00M 10-K · filed 2026-02-10 |
| 2023-12-31 | $5.00M 10-K · filed 2026-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |